Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
26 /100
MEDIUM RISK
Score updated Oct 13, 2026

RAPP — Rapport Therapeutics, Inc. Dilution Risk Tracker

Track RAPP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RAPP — Get alerts when the score changes →

As of October 13, 2026, Rapport Therapeutics, Inc. (RAPP) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Rapport Therapeutics, Inc. has a market capitalization of $1.45B, 47.98M shares outstanding, 148 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $110.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
27
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $110M remaining capacity
🔔 Track RAPP — Get forecast alerts →

Market Data

Market Cap$1.45B
Shares Outstanding47.98M
Float31.75M
Cash$436.08M
Debt$10.80M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore26/100DilutionWatch score record
Shares Outstanding47.98MVerified float table or market cache
Public Float31.75MVerified float table or market cache
Market Cap$1.45BMarket data cache
Cash Runway48.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$110.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: 4 5.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 19.6% shares (2026Q1 vs prior)
148 institutional holders · 61.74M shares
#1 FMR LLC 7.17M shares
#2 TRV GP V, LLC 7.14M shares
#3 GOLDMAN SACHS GROUP INC 5.94M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.19M
Days to Cover4.8
% of Float10.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

4 INSIDER TRANSACTION 2026-03-31
4 INSIDER TRANSACTION 2026-03-26
4 INSIDER TRANSACTION 2026-03-09
4 INSIDER TRANSACTION 2026-02-19
4 INSIDER TRANSACTION 2026-02-04
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual RAPP Dilution Snapshot

Rapport Therapeutics, Inc. (RAPP) has a DilutionScore of 26/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

RAPP's DilutionScore is currently 26/100 (Medium risk), with 2 score changes tracked over 89 days. The score improved from 25/100 (Low risk).

Period Score Risk Level Duration
Oct 13, 202626/100MEDIUM1 day
Sep 05 – Oct 12, 202625/100LOW38 days
Jul 16 – Sep 04, 202634/100MEDIUM50 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

RAPP shares outstanding have increased 0.3% from 47.66M (Mar 2026) to 47.83M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 28, 202647.83M31.75M▲ 1.31%
May 19, 202647.83M31.34M▲ 0.22%
May 16, 202647.83M31.27M▲ 0.02%
May 09, 202647.83M31.26M▲ 0.07%
Apr 28, 202647.81M31.23M▲ 1.38%
Apr 24, 202647.81M30.81M▲ 0.07%
Apr 17, 202647.79M30.79M▲ 0.10%
Mar 28, 202647.79M30.76M▲ 0.03%
Mar 24, 202647.79M30.75M▼ 0.02%
Mar 14, 202647.66M30.75M▲ 0.15%
Mar 11, 202647.66M30.70M▲ 0.28%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track RAPP Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment RAPP files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking RAPP — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for RAPP
RAPP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.